RT Journal Article
SR Electronic
T1 Protection of health care workers from exhaled air of patients operated under local, regional, spinal or epidural anaesthesia during COVID 19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.26.20192823
DO 10.1101/2020.11.26.20192823
A1 Kuldeepsinh Pradipkumar Atodaria
A1 Mayank Singh
A1 Vimalkumar Prajapati
A1 Kush Shaileshkumar Shah
A1 Pradipkumar Raghuvirsinh Atodaria
YR 2020
UL http://medrxiv.org/content/early/2020/12/02/2020.11.26.20192823.abstract
AB The SARS-CoV-2 (COVID-19) pandemic mandates the use of N-95/FFP-2 masks for healthcare workers, especially in operation room (OR) for surgical or aerosol producing procedures. During pandemic, surgical interventions such as limb trauma, limb amputations, and limb malignancies continued to flow into the hospitals and are normally performed under local, regional or spinal anaesthesia. N-95/FFP-2 masks normally do not prevent escape of exhaled air to surrounding and to avoid the escape of exhaled unfiltered air, sealing masks by taping its edges to face possibly serves the purpose, but causes significant discomfort to patients. HEPA filters, high vacuum suction apparatus, and negative pressure operating-room may protect partially against the-risk of infection if patient’s exhaled air is infected. In order to reduce risk of transmission from patients’ exhaled air to the healthcare workers, a technique has been designed to divert the patients’ exhaled air to outside the-OR using a suction machine. This technique is easy, simple and cost-effective and trial has been performed with four-volunteers to see feasibility to breathe through N-95 mask sealed by sticking its edges to face using tape. The trial reflected reduction in SpO2, causing increased respiratory-rate, tachycardia and hypertension, in-addition an un-acclimatized volunteers had difficulty in breathing through sealed N-95 masks, which was relieved by supplying oxygen to them. Attaching suction system to remove the-exhaled air aids to comfort levels. Treating exhaled-air with sodium-hypochlorite and diverting it externally to an open-space outside the-OR added to safety for the patients, surgical team and the hospital surroundings.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCTRI/2020/11/029394Funding StatementWe have not received anykind of funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/ Etics committee of Unique Hospital-multispeciality and research Institute (Ethic committee No. ECR/595/Inst/GJ/2014/RR-17 approved by Directorate General of Health Srvices, Central Drugs Standard control organization, Govt Of India)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have included all the necessary data generated during the performed surgeries. As well we followed the authors submission guidelines of the Medrxiv to put up the data fromat in manuscript.